Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.15
+0.02 (0.22%)
Aug 7, 2025, 4:00 PM - Market closed
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $6.79 million as of August 8, 2025. Its market cap has increased by 2.01% in one year.
Market Cap
6.79M
Enterprise Value
3.35M
1-Year Change
2.01%
Ranking
Category
Stock Price
$8.15
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $6.79M, a decrease of -97.90%. That is a compound annual growth rate of -19.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 6.79M | 9.57% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | 60.25M | 34.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 667.50B |
| Johnson & Johnson | 412.04B |
| AbbVie | 345.06B |
| Novartis AG | 228.98B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 228.37B |
| UnitedHealth Group | 224.17B |
| Novo Nordisk | 200.63B |